| DC47379 | 
                                1,2-Didecanoylglycerol
                                 | 
                                1,2-Didecanoylglycerol, a synthetic diacylglycerol, is metabolized by platelets to 1,2-didecanoylphosphatidic acid (PA10) and activates protein kinase C (PKC). | 
                            
                            
                            
                                | DC47378 | 
                                (±)-1,2-Diolein
                                 | 
                                (±)-1,2-Diolein (1,2-Dioleoyl-rac-glycerol) is a PKC activator. | 
                            
                            
                            
                                | DC47209 | 
                                PF-04577806
                                 | 
                                PF-04577806 is a potent, selective and ATP competitive PKC inhibitor. PF-04577806 shows potent inhibitory activity towards PKCα, PKCβI, PKCβII, PKCγ, and PKCθ with IC50s of 2.4 nM, 8.1 nM, 6.9 nM, 45.9 nM, and 29.5 nM, respectively. PF-04577806 can reverse retinal vascular leakage in diabetic rats. | 
                            
                            
                            
                                | DC47189 | 
                                Bryostatin 3
                                 | 
                                Bryostatin 3, a macrocyclic lactone, is a protein kinase C activator, with a Ki of 2.75 nM. Bryostatin 3 can block 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibition of cell proliferation, yet did not block TPA-enhanced cell-substratum adhesion. | 
                            
                            
                            
                                | DC47156 | 
                                Sangivamycin
                                 | 
                                Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers. | 
                            
                            
                            
                                | DC46989 | 
                                Myelin Basic Protein TFA
                                 | 
                                Myelin Basic Protein (MHP4-14) TFA, a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (Km=7 μM). Myelin Basic Protein TFA is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca2+/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts. | 
                            
                            
                            
                                | DC46927 | 
                                PF-03622905
                                 | 
                                PF-03622905 is a potent and ATP-competitive PKC inhibitor with IC50s of 5.6 nM, 14.5 nM, 13 nM, 37.7 nM, and 74.1 nM for PKCα, PKCβI, PKCβII, PKCγ, and PKCθ, respectively. PF-03622905 shows high specificity for PKC over other protein kinases. | 
                            
                            
                            
                                | DC46926 | 
                                Bisindolylmaleimide XI hydrochloride
                                 | 
                                Bisindolylmaleimide XI hydrochloride (Ro 32-0432) is a potent, selective and orally active PKC inhibitor with IC50s of 9 nM, 28 nM, 31 nM, 37 nM, and 108 nM for PKCα, PKCβI, PKCβII, PKCγ, and PKCε, respectively. | 
                            
                            
                            
                                | DC46505 | 
                                Mezerein
                                 | 
                                Mezerein is a PKC activator that exhibits antileukemic properties. Mezerein inhibits the growth of yeast expressing PKC alpha (IC50=1190 nM), PKC beta1 (IC50=908 nM), and PKC delta (IC50=141 nM) but not of yeast expressing PKC. | 
                            
                            
                            
                                | DC45863 | 
                                Leucosceptoside A
                                 | 
                                Leucosceptoside A is a phenylethanoid glycoside with anti-hyperglycemic and anti-hypertensive activities. Leucosceptoside A shows inhibitory activity against α-glucosidase and PKCα (IC50 of 19.0 μM). |